Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Abuse Potential and Safety

NCT05729932 is registered in ClinicalTrials.gov with Shanna Babalonis, PhD as lead sponsor.

NCT NCT05729932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05729932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Abuse Potential and Safety
Lead sponsor
Shanna Babalonis, PhD
Phase
Phase 1
Overall status
Recruiting
Start date
September 10, 2024
Completion date
June 30, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder